Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome

Journal of Clinical Investigation

Volumn 118, Issue 4, 2008, Pages 1458-1467

  Rahmouni, Kamal ^a   Fath, Melissa A ^a   Seo, Seongjin ^a   Thedens, Daniel R ^a   Berry, Christopher J ^a   Weiss, Robert ^a   Nishimura, Darryl Y ^a   Sheffield, Val C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPETITE; ARTERIAL PRESSURE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BARDET BIEDL SYNDROME; BODY WEIGHT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GANGLION BLOCK; HEART WEIGHT; HYPERLEPTINEMIA; HYPERPHAGIA; HYPERTENSION; HYPOTHALAMUS; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPATHETIC NERVE;

ANIMALS; BARDET-BIEDL SYNDROME; BLOOD-BRAIN BARRIER; BODY WEIGHT; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; GENE EXPRESSION REGULATION; HYPERTENSION; LEPTIN; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR CHAPERONES; OBESITY; ORGAN SIZE; PROTEINS;

EID: 41849134729     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32357     Document Type: Article

References (46)

1. Green, J.S., et al. 1989. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N. Engl. J. Med. 321:1002-1009.
2. Blacque, O.E., and Leroux, M.R. 2006. Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cell. Mol. Life Sci. 63:2145-2161.
3. Harnett, J.D., et al. 1988. The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N. Engl. J. Med. 319:615-618.
4. Elbedour, K., Zucker, N., Zalzstein, E., Barki, Y., and Carmi, R. 1994. Cardiac abnormalities in the Bardet-Biedl syndrome: echocardiographic studies of 22 patients. Am. J. Med. Genet. 52:164-169.
5. Benzinou, M., et al. 2006. Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians. Diabetes. 55:2876-2882.
6. Mykytyn, K., et al. 2002. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat. Genet. 31:435-438.
7. Nishimura, D.Y., et al. 2001. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum. Mol. Genet. 10:865-874.
8. Chiang, A.P., et al. 2004. Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am. J. Hum. Genet. 75:475-484.
9. Mykytyn, K., et al. 2001. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat. Genet. 28:188-191.
10. Li, J.B., et al. 2004. Comparative and basal genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell. 117:541-552.
11. Slavotinek, A.M., et al. 2000. Mutations in MKKS cause Bardet-Biedl syndrome. Nat. Genet. 26:15-16.
12. Badano, J.L., et al. 2003. Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am. J. Hum. Genet. 72:650-658.
13. Ansley, S.J., et al. 2003. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature. 425:628-633.
14. Nishimura, D.Y., et al. 2005. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am. J. Hum. Genet. 77:1021-1033.
15. Stoetzel, C., et al. 2006. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat. Genet. 38:521-524.
16. Chiang, A.P., et al. 2006. Homozygosity mapping with SNP arrays identifies TRIM32 an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc. Natl. Acad. Sci. U. S. A. 103:6287-6292.
17. Stoetzel, C., et al. 2007. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am. J. Hum. Genet. 80:1-11.
18. Ansley, S.J., et al. 2003. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature. 425:628-633.
19. Badano, J.L., Mitsuma, N., Beales, P.L., and Katsanis, N. 2006. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genomics Hum. Genet. 7:125-148.
20. Chiang, A.P., et al. 2004. Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am. J. Hum. Genet. 75:475-584.
21. Nishimura, D.Y., et al. 2004. Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc. Natl. Acad. Sci. U. S. A. 101:16588-16593.
22. Mykytyn, K., et al. 2004. Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc. Natl. Acad. Sci. U. S. A. 101:8664-8669.
23. Fath, M.A., et al. 2005. Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum. Mol. Genet. 14:1109-1118.
24. Ross, A.J., et al. 2005. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat. Genet. 37:1135-1140.
25. Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., and Schwartz, M.W. 2006. Central nervous system control of food intake and body weight. Nature. 443:289-295.
26. Friedman, J.M., and Halaas, J.L. 1998. Leptin and the regulation of body weight in mammals. Nature. 395:763-770.
27. Banks, W.A., Kastin, A.J., Huang, W., Jaspan, J.B., and Maness, L.M. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:305-311.
28. Elmquist, J.K., Bjorbaek, C., Ahima, R.S., Flier, J.S., and Saper, C.B. 1998. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395:535-547.
29. Schwartz, M.W., and Porte, D., Jr. 2005. Diabetes, obesity, and the brain. Science. 307:375-379.
30. Rahmouni, K., Correia, M.L., Haynes, W.G., and Mark, A.L. 2005. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 45:9-14.
31. Correia, M.L., et al. 2002. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes. 51:439-442.
32. Rahmouni, K., Morgan, D.A., Morgan, G.M., Mark, A.L., and Haynes, W.G. 2005. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes. 54:2012-2018.
33. Flier, J.S. 2004. Obesity wars: molecular progress confronts an expanding epidemic. Cell. 116:337-350.
34. Moore, S.J., et al. 2005. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am. J. Med. Genet. A. 132:352-360.
35. Grace, C., et al. 2003. Energy metabolism in Bardet-Biedl syndrome. Int. J. Obes. Relat. Metab. Disord. 27:1319-1324.
36. Ryan, M.J., McLemore, G.R., Jr. and Hendrix, S.T. 2006. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Hypertension. 48:988-993.
37. Hanada, R., et al. 2004. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat. Med. 10:1067-1073.
38. Stepanyan, Z., et al. 2003. Leptin-target neurones of the rat hypothalamus express somatostatin receptors. J. Neuroendocrinol. 15:822-830.
39. Baly, C., et al. 2007. Leptin and its receptors are present in the rat olfactory mucosa and modulated by the nutritional status. Brain Res. 1129:130-141.
40. Yen, H.J., et al. 2006. Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum. Mol. Genet. 15:667-677.
41. Rahmouni, K., Haynes, W.G., Morgan, D.A., and Mark, A.L. 2003. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J. Neurosci. 23:5998-6004.
42. DiBona, G.F., and Kopp, U.C. 1997. Neural control of renal function. Physiol. Rev. 77:75-197.
43. Barnes, M.J., et al. 2003. High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors. Brain Res. Bull. 61:511-519.
44. Kassab, S., et al. 1995. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 25:893-897.
45. Nachury, M.V., et al. 2007. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell. 129:1201-1213.
46. Weiss, R.M., Ohashi, M., Miller, J.D., Young, S.G., and Heistad, D.D. 2006. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 114:2065-2069.